Singapore strategises advance modalities for cancer- and age-related muscle degeneration

The global population is aging rapidly, and sarcopenia, a condition that severely diminishes quality of life in older ad...

September 26, 2024 | Thursday | News
Bio-Sourcing secures EIC Accelerator funding to enhance biomanufacturing

Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces the award of €2.5M in grants and €10M in ...

September 24, 2024 | Tuesday | News
Antibody Engineering & Therapeutics Asia 2024: A Premier Gathering for Cutting-Edge Antibody Research and Innovation

Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...

September 1, 2024 | Sunday | News
Australia designs world first wearable device to record impact of artificial light for sound sleep

In a world first, a new wearable device developed by Australia's Monash University researchers will help to record the i...

August 25, 2024 | Sunday | News
Singapore approves GSK's Jemperli plus chemotherapy as first frontline immuno-oncology treatment

GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperl...

August 8, 2024 | Thursday | News
Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute's MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...

August 7, 2024 | Wednesday | News
Abu Dhabi announces first gene transfer therapy for duchenne muscular dystrophy

Department of Health – Abu Dhabi (DoH) has provided revolutionary gene transfer therapy for Duchenne muscular dyst...

August 6, 2024 | Tuesday | News
Boston Oncology to advance localised cell and gene therapies in Saudi Arabia

Under an important initiative aimed at transforming healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King ...

August 2, 2024 | Friday | News
Singapore MOH includes Roche’s spinal muscular atrophy (SMA) drug in MAF framework

EVRYSDI® (risdiplam) has been added to the Singapore Ministry of Health’s (MOH) list of medicines covered...

August 1, 2024 | Thursday | News
Addressing Root Causes of Brain Disorders with Innovative Therapeutics

The global CNS disorders market, in 2022, was valued at $116 billion, ranking it as the fourth largest therapy area behi...

August 1, 2024 | Thursday | Analysis
Hong Kong researchers suggest novel treatment approaches for glaucoma

Dr Samantha SHAN, Research Assistant Professor of the School of Optometry of The Hong Kong Polytechnic University (PolyU...

July 27, 2024 | Saturday | News
China-based startup Triastek to advance 3D printed oral RNA therapeutics in $1.2 B deal with BioNTech

Triastek Inc., a global leader in 3D printing pharmaceuticals, has entered into a research collaboration and platform te...

July 23, 2024 | Tuesday | News
Australia, UK develop new antidote for snake bites using CRISPR technology

Scientists at the University of Sydney, Australia and Liverpool School of Tropical Medicine, UK have made a remarkable d...

July 23, 2024 | Tuesday | News
GC Cell, Lukas jointly tap into innovative cell therapy in Korea and Taiwan

GC Cell Corporation and Taiwan-based Lukas Biomedical has formally signed an international strategic cooperation agreeme...

July 22, 2024 | Monday | News
Funding boost for study on early childhood allergies in Singapore

A team of scientists led by Associate Professor Ashley St John from Duke-NUS’ Emerging Infectious D...

July 15, 2024 | Monday | News
Researchers from Japan discover new enzyme with promising antibacterial activity

Acute graft-versus-host disease (aGVHD) is a medical condition that occurs when donor immune cells attack the recipient'...

July 15, 2024 | Monday | News
Hong Kong identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders

The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among ...

July 12, 2024 | Friday | News
TMS partners with Hokkaido University in Japan to develop treatment for spinal cord injury

TMS Co. has entered into an exclusive worldwide license agreement with Hokkaido University concerning a therapeuti...

July 9, 2024 | Tuesday | News
Australia-India strategic research fund lays focus on combatting AMR and microbial infections

Union Minister for Science and Technology, Government of India, Dr Jitendra Singh has unveiled the results of the 15th r...

July 5, 2024 | Friday | News
Australia develops new transparent blood vessel-on-a-chip

A University of Sydney team have successfully created a transparent microchip with the potential to reduce the testing o...

July 3, 2024 | Wednesday | News
Scientists in Singapore discover unexpected molecular heterogeneity in same liver tumours, provide better understanding of disease

A study led by clinician-scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s G...

June 24, 2024 | Monday | News
Hong Kong develops innovative mRNA drug for treatment of nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC) is a cancer type strongly associated with Epstein-Barr virus (EBV) infection. The Chinese...

June 21, 2024 | Friday | News
New biotech company in Australia to tackle hard-to-treat cancers

A new biotech company launched on 18th June in Australia will use a world-leading technology to target cancers that are ...

June 18, 2024 | Tuesday | News
Thermo Fisher, NUH, Mirxes collaborate to enhance access to early cancer detection genomic tests in Singapore

To increase patient access to affordable, advanced genomic testing for cancer in Singapore, Thermo Fisher Scientific Inc...

June 14, 2024 | Friday | News
Emergence of Cell and Gene Therapy Community in Singapore

Having previously pivoted towards medical devices more than 10 years ago, Singapore has recently seen a biotech resurgen...

June 14, 2024 | Friday | Opinion

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls